<?xml version="1.0" encoding="UTF-8"?>
<p id="Par34">Cancer with bone metastases compared to other metastatic sites is considered as associated with a better prognosis, particularly for breast and prostate cancer despite a significant impact on the patient’s quality of life and autonomy. Many randomized controlled trials have demonstrated the efficacy of first-line palliative conventional radiotherapy for painful bone metastases [
 <xref ref-type="bibr" rid="CR1">1</xref>–
 <xref ref-type="bibr" rid="CR4">4</xref>]. The advent of novel imaging techniques allows an increasing an early detection and diagnosis of oligometastatic disease. In clinical practice the possibility to identify a few number of lesions, better defined recently by ASTRO, EORTC and ESTRO, it is considered an intermediate phase of tumor spread with limited metastatic capacity [
 <xref ref-type="bibr" rid="CR5">5</xref>, 
 <xref ref-type="bibr" rid="CR6">6</xref>].
</p>
